Evidence map›Paper›PMID 23589370›Full record

ArticleThe Journal of biological chemistry2013

IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity.

Jun-Ming Liao, Yu Zhang, Wenjuan Liao, Sheyla X Zeng, Xiaohua Su, Elsa R Flores, Hua Lu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jun-Ming LiaoDepartment of Biochemistry and Molecular Biology and Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Yu Zhang
Wenjuan Liao
Sheyla X Zeng
Xiaohua Su
Elsa R Flores
Hua Lu
Tulane University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancerR01CA160394 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FLORES, ELSA R · 2012 to 2015
$2.0M
MOLECULAR DISSECTION OF A NOVEL P53 LIKE PROTEINR01CA079721 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LU, HUA · 1999 to 2006
$1.8M
Investigating the role of p73 and its isoforms in tumorigenesis and metastasisR01CA134796 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FLORES, ELSA R · 2009 to 2013
$1.6M
Role of ribosomal proteins in regulating c-MycR01CA129828 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2008 to 2012
$1.5M
Dual Targeting of the p53 pathway for development of anti-cancer therapyR01CA172468 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2012 to 2016
$1.5M
NCI NIH HHS CA079721NCI NIH HHS CA129828NCI NIH HHS CA134796NCI NIH HHS CA172468NCI NIH HHS R01 CA079721NCI NIH HHS R01 CA129828NCI NIH HHS R01 CA134796NCI NIH HHS R01 CA160394NCI NIH HHS R01 CA172468PHS HHS NCI 095441
6 · The paper itself

Abstract

Previously, we reported that IκB kinase-β(IKKβ) phosphorylates and stabilizes TAp63γ. However, the effect of this phosphorylation on TAp63γ transcriptional activity remains unclear. In this study, we showed that overexpression of IKKβ, but not its kinase dead mutant and IKKα, can surprisingly inhibit TAp63γ transcriptional activity as measured by luciferase assays and real-time PCR analyses of p63 target genes. This inhibition was impaired by ACHP, an IKKβ inhibitor, and enhanced by TNFα that activates IKKβ. Consistently, IKKβ inhibited the binding between TAp63γ and p300, a co-activator of TAp63γ, and consequently counteracted the positive effect of p300 on TAp63γ transcriptional activity. Through phosphorylation site prediction and mass spectrometry, we identified that Ser-4 and Ser-12 of p63 are IKKβ-targeting residues. As expected, IKKβ fails to suppress the transcriptional activity of the S4A/S12A double mutant p63. These results indicate that IKKβ can suppress TAp63γ activity by interfering with the interaction between TAp63γ and p300.

Indexed as

Transcriptional ActivationBinding SitesBlotting, WesternCell Line, TumorCyclin-Dependent Kinase Inhibitor p21E1A-Associated p300 ProteinGene ExpressionHumansI-kappa B KinaseMicroRNAsMutationNicotinic AcidsNitrilesPhosphorylationProtein BindingProtein Isoforms2-amino-6-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-4-piperidin-4-yl nicotinonitrileCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21E1A-Associated p300 ProteinEP300 protein, humanI-kappa B KinaseMicroRNAsMIRN34 microRNA, humanNicotinic AcidsNitrilesProtein IsoformsSerineTP63 protein, humanTranscription FactorsTumor Necrosis Factor-alphaTumor Suppressor ProteinsIκB kinase-βp300p63SenescenceSignal transductionTranscriptionTumor Necrosis Factor (TNF)

Identifiers

PMID23589370
PMCPMC3689961
OpenAlexW1518492079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.